GlassScriptPhysician profile
Kevan T Iffrig
NPI 1215347471
$1,709.11
in general payments reported to CMS, 2019-2025
8 companies · $144 in 2025
The $144 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $441 · 2023: $60.51 · 2024: $1,063 · 2025: $144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,015 · Food and Beverage: $252.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,015.20 |
| Food and Beverage | $252.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $1,015.20 | 2024 | Aquabeam System |
| Boston Scientific Corporation | $430.41 | 2019 | |
| Pfizer INC. | $124.65 | 2025 | |
| Myriad Genetic Laboratories, INC. | $67.63 | 2023-2025 | Prolaris |
| Medtronic, INC. | $28.06 | 2023 | Interstim |
| Bayer Healthcare Pharmaceuticals INC. | $16.72 | 2023 | |
| Coloplast Corp | $15.38 | 2024 | |
| Travere Therapeutics, INC. | $11.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevan Iffrig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.